Rebiotix, a Ferring company, completes enrollment for phase 3 clinical trial of microbiota-based RBX2660

Rebiotix, a Ferring company, completes enrollment for phase 3 clinical trial of microbiota-based RBX2660. (Credit: PublicDomainPictures from Pixabay)